American Society for Clinical Pathology (ASCP), College of American Pathologists (CAP), Association for Molecular Pathology (AMP), and American Society of Clinical Oncology (ASCO) have released a new, evidence-based clinical practice guideline on molecular marker testing for patients with colorectal carcinoma that identifies opportunities for improving patient outcomes.
This pivotal guideline addresses a wide range of molecular markers appropriate for testing in patients with early and advanced colorectal cancer. This guideline will aid in establishing standard molecular marker testing to help guide targeted therapy decisions, and advance personalized care for colorectal cancer patients.
Go here to access the paper.
Speaker: Antonia R. Sepulveda MD, PhD
Duration: 1.0 hr
Level of Instruction: Basic
This course is approved by the American Board of Pathology for 1.0 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly). To access the quiz, click on the "submit credit" button in your classroom.
Note: SAM credit is available to all for $10 until October 2017. To continue receiving the discounted price after October, become an AMP member.
March 31, 2017
American Board of Pathology
Self-Assessment Module: 1.00
AMP Regular Member: $10.00
AMP Technologist Member: $10.00
AMP Associate Member: $10.00
Non-member Price: $10.00